Category Archives: Healthcare

Benchmark Co. Releases a Buy Rating on Heska Corp

468849.jpg

In a report released today, Raymond Myers from Benchmark Co. reiterated a Buy rating on Heska Corp (NASDAQ: HSKA), with a price target of $106. The company’s shares closed yesterday at $92.74, close to its 52-week high of $95.39. According

H.C. Wainwright Reiterates a Buy Rating on Lexicon Pharmaceuticals

468829.jpg

In a report released today, Shaunak Deepak from H.C. Wainwright reiterated a Buy rating on Lexicon Pharmaceuticals (NASDAQ: LXRX), with a price target of $27. The company’s shares closed yesterday at $16.04. According to TipRanks.com, Deepak is ranked 0 out

Needham Releases a Buy Rating on GenMark

468823.jpg

In a report released today, Michael Matson from Needham reiterated a Buy rating on GenMark (NASDAQ: GNMK), with a price target of $15. The company’s shares closed yesterday at $11.32. Matson wrote: “GNMK’s 4Q16 revenue was consistent with its 1/10/17

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Atricure (NASDAQ: ATRC) and Valeant Pharma (NYSE: VRX)

468815.png

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Atricure (NASDAQ: ATRC) and Valeant Pharma (NYSE: VRX). Atricure (NASDAQ: ATRC) In a report released today, Michael Matson from Needham reiterated a Buy rating on

Oppenheimer Releases a Buy Rating on Dexcom

468811.jpg

In a report released today, Steven Lichtman from Oppenheimer reiterated a Buy rating on Dexcom (NASDAQ: DXCM), with a price target of $98. The company’s shares closed yesterday at $78.16. Lichtman commented: “4Q16 revenue of $171.2M (+31%) was above DXCM’s

Oppenheimer Reiterates a Hold Rating on Endo International

468805.png

Oppenheimer analyst Derek Archila reiterated a Hold rating on Endo International (NASDAQ: ENDP) today. The company’s shares closed yesterday at $13.65, close to its 52-week low of $11.37. Archila noted: “ENDP reported a 4Q sales/EPS beat and provided 2017 sales